May 23-27, 2009 | York University, Toronto, Canada

Our Sponsors


  OFFICIAL SPONSORS
 
Integra Foundation
Integra NeuroSciences is a leading provider of implants, devices, instruments, and systems used in neurosurgery, neuromonitoring, neuro-trauma, and related critical care. We offer the leading products for monitoring intracranial pressure (the Camino® ICP monitor) and metabolic activity (LICOX® brain tissue oxygen monitoring system) and equipment for the drainage of excess cerebral spinal fluid (the AccuDrain™ and LimiTorr™ External Ventricular Drainage Systems).
Our Camino® and LICOX® monitoring systems are used in the treatment of Traumatic Brain Injury ("TBI"). TBI is a major public health problem and costs the U.S. an estimated $56 billion a year. More than 5 million Americans alive today have had a TBI, resulting in a permanent need for help in performing daily activities, and TBI survivors are often left with significant cognitive, behavioral, and communicative disabilities.
Our Accudrain™ and LimiTorr™ CSF drainage systems are utilized for ventricular or lumbar cerebral spinal fluid (CSF) drainage. LimiTorr™ is the latest addition to Integra's CSF drainage product line and the first volume-limiting CSF management system on the market. It includes a volume-limiting valve mechanism, which halts drainage when the pre-determined volume of 20 mL or 30 mL is met. This safety mechanism helps prevent CSF overdrainage, which can lead to subdural hematomas, brainstem herniation or death.
Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is dedicated to improving the quality of life for patients through the development, manufacturing, and marketing of cost-effective surgical implants and medical instruments. The company's products are used to treat millions of patients every year, primarily in neurosurgery, extremity reconstruction, orthopedics and general surgery. Integra's headquarters are in Plainsboro, New Jersey, and it has research and manufacturing facilities throughout the world.
Codman
Codman, a Johnson & Johnson company, is a global neuroscience device company that offers a broad range of devices and therapies to treat patients with neurological diseases and conditions. The company, which is a part of the DePuy Franchise, will work with health care providers to forge a new era of innovation in the care and treatment of these patients.
Codman markets one of the most broad and comprehensive lines of neurosurgical implants, disposables, equipment and instruments specializing in hydrocephalus, neuro critical care, neurosurgical access and intervention, implantable drug delivery solutions and minimally invasive treatments for neurovascular disorders.
Equally important, Codman is uniquely positioned to leverage the knowledge, capabilities and resources within Johnson & Johnson to develop and deliver future technologies to treat these patients and address unmet needs. We are headquartered in Raynham, Massachusetts and employ over 500 people worldwide.
In addition, our effectiveness in the marketplace depends upon close contact with the surgical community we serve. Surgeons, operating room nurses hospital administrators and the company’s field sales representatives routinely call on other healthcare professionals.
Today, Codman continues to expand its operations and its horizons. Through quality products, a tradition of unmatched customer service, and high standards of integrity, Codman looks forward to continued growth and service to meet the ever-expanding needs of our customers and employees.
NNF
The Neuroscience Nursing Foundation was established in 1993 in order to ensure the highest quality of care for people with neuroscience disorders, educate the general public about the care of neuroscience patients, and promote the unique specialty of neuroscience nursing. Since its establishment, the Foundation has provided education and research opportunities for registered nurses furthering their careers in the neurosciences. It is the only Foundation dedicated solely to neuroscience nurses.
CANN
CANN was founded in 1969 by a group of neuroscience nurses as an organization to promote collaboration and knowledge dissemination across Canada. Over time it has developed and has as its mission: To set standards of practice and promote continuing professional education and research.
Members of CANN collaborate with individuals, families, interdisciplinary teams and communities to prevent illness and to improve health outcomes for people with, or at risk, for neurological disorders.
Faculty of Health at York University
Established on July 1, 2006 the Faculty of Health is an innovative and supportive environment for learning, teaching and discovery. It is on an exceptional mission to build a leading centre of innovation, excellence and compassion in health and human sciences. Our vision is to educate future global leaders in redefining and advancing health and human science. Through exceptional education and research, we emphasize effective approaches for keeping people and communities healthy and sustaining our health systems.
ONF
The Ontario Neurotrauma Foundation (ONF) is an applied health research organization with a focus on improving the quality of life of people who have sustained acquired brain injury or spinal cord injury, and on preventing neurotrauma injuries from occurring in the first place. Neurotrauma injuries affect over half a million people in the province of Ontario and create a cost burden to the province in the order of $2- 3 billion annually.
ONF uses strategic research funding activity within its three programs (Neurotrauma Prevention, Acquired Brain Injury, and Spinal Cord Injury). These research activities are embedded within a knowledge mobilization framework to build capacity and create movement for change. The foundation receives its funding from the Ontario Government through the Ministry of Health and Long-Term Care.
AANN
The American Association of Neuroscience Nurses (AANN), with more than 4,700 members world wide, is committed to working for the highest standard of care for neuroscience patients by advancing the science and practice of neuroscience nursing. AANN promotes education, standard setting, and advocacy on behalf of neuroscience patients, families, and nurses.
WFNN
Founded in 1969, the World Federation of Neuroscience Nurses (WFNN) initially consisted of nursing organizations representing five member countries. During the past three decades, that number has grown to 16 member organizations spread over five continents. Growth has kept pace with innovations in medicine and the increasingly important role of neuroscience nursing specialty organizations.
WFNN is the host organization once every four years for the largest international gathering of neuroscience nurses and affiliated specialties to compare notes, to network, and to build a firmer foundation for healthcare by emerging nations.